Aberdeen Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Aberdeen Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$978K	Hold	66,062	–	–	﹤0.01%	687
2017 Q1	$1.05M	Hold	66,062	–	–	﹤0.01%	650
2016 Q4	$832K	Hold	66,062	–	–	﹤0.01%	656
2016 Q3	$1.85M	Hold	66,062	–	–	0.01%	583
2016 Q2	$2.31M	Hold	66,062	–	–	0.01%	541
2016 Q1	$1.81M	Hold	66,062	–	–	0.01%	571
2015 Q4	$1.61M	Buy	+66,062	New	+$2.06M	0.01%	591

Other funds holding DPLO

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aberdeen Asset Management's DPLO Position: Q2 2017 in Review

Aberdeen Asset Management held its DIPLOMAT PHARMACY, INC. (DPLO) position steady in Q2 2017 at 66,062 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Aberdeen Asset Management first reported a position in DPLO in Q4 2015 and has held it in 7 quarters since. The position peaked at $2.31M in Q2 2016. 175 funds tracked by Wall St. Rank hold DPLO as of Q2 2017.

Aberdeen Asset Management held 66,062 shares of DIPLOMAT PHARMACY, INC. worth $978K as of Q2 2017.
Aberdeen Asset Management left its DIPLOMAT PHARMACY, INC. share count unchanged in Q2 2017.
DIPLOMAT PHARMACY, INC. made up ﹤0.01% of Aberdeen Asset Management's portfolio in Q2 2017, its #687 holding.
Aberdeen Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and has held it in 7 quarters since.
Aberdeen Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $2.31M in Q2 2016.
175 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.